
Minoxidil
Minoxidil tablets are a last-line prescription medicine for severe, hard-to-control high blood pressure, with a boxed warning about fluid around the heart and worsening chest pain. Topical minoxidil 2% and 5% is an over-the-counter treatment that regrows some hair on the top of the scalp in hereditary hair loss, as shown in placebo-controlled trials in men and women. Low-dose minoxidil tablets for hair loss are widely discussed but are not an FDA-approved use; small trials found results similar to topical minoxidil, with more unwanted body hair.
Over-the-counter medication: not a dietary supplement
This is an FDA-approved drug sold without a prescription (some strengths are prescription only). It is not a supplement. The information below is for education only. Ask your doctor or pharmacist before combining it with supplements or other medicines.
Quick decision guide
May help most
Tablets: adults with severe high blood pressure not controlled by a diuretic plus two other drugs, under close medical supervision. Topical: adults 18 and older with gradual, hereditary thinning on the top of the scalp
Common dosing range
Tablets: set by your prescriber; label start 5 mg once daily for patients over 12, usual range 10 to 40 mg a day, maximum 100 mg a day, usually with a diuretic and a beta blocker. Topical: follow the Drug Facts label (for example 1 mL of solution twice a day, or half a capful of foam once or twice a day depending on the product)
When to expect effects
Blood pressure: after a single dose it starts to fall within half an hour and is lowest at 2 to 3 hours; on a steady daily dose the full effect is reached within 3 to 7 days (7 days on 10 mg a day, 3 days on 40 mg a day). Hair: the labels say results may appear at 2 to 3 months and may take 4 to 6 months
Watch out for
Tablets carry a boxed warning: they can cause fluid around the heart (pericardial effusion), sometimes progressing to tamponade, and can worsen angina; they need close supervision, usually with a diuretic and a beta blocker. Topical products: the Drug Facts labels say to stop use and ask a doctor if chest pain, fast heartbeat, faintness, dizziness, sudden weight gain or swollen hands or feet occur. Using tablets for hair loss is off-label
What is it
Minoxidil is an FDA-approved drug that comes in two very different forms. Minoxidil tablets (2.5 mg and 10 mg) are a prescription blood pressure medicine with a boxed warning, approved only for severe high blood pressure that causes symptoms or organ damage and is not controlled by the highest doses of a diuretic plus two other blood pressure drugs. Minoxidil topical solution and foam (2% and 5%, sold over the counter as Rogaine and many store brands) are approved to regrow hair on the top of the scalp in hereditary pattern hair loss. Taking low-dose minoxidil tablets for hair loss is off-label: the tablet label says that use of minoxidil tablets, in any formulation, to promote hair growth is not an approved indication. This page covers the tablets taken by mouth and the solution or foam applied to the scalp.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
male pattern hair loss (androgenetic alopecia), topical minoxidil Good Evidence | 5% solution gave 45% more regrowth than 2% at 48 weeks; both beat placebo | Men aged 18 to 49 with moderate thinning on the top of the scalp | Hair count gains by 16 weeks; trials ran to 48 weeks |
female pattern hair loss, topical minoxidil Good Evidence | Risk ratio 1.93 for moderate to marked regrowth versus placebo; +13.18 hairs per cm2 | Adult women with gradual, hereditary thinning on the top of the scalp | Months; the women's Drug Facts labels say results may take 4 to 6 months |
pattern hair loss, low-dose minoxidil tablets (off-label) Limited Evidence | No significant difference from topical minoxidil in hair density | Adults with pattern hair loss in dermatology trials who were screened by a doctor | Trials lasted 24 to 39 weeks |
resistant high blood pressure, minoxidil tablets Mixed Evidence | Blood pressure about 27/10 mmHg lower at discharge than at the start of minoxidil | Adults with chronic kidney disease whose blood pressure stays high despite several drugs, treated in hospital | Days, during the hospital stay |
male pattern hair loss (androgenetic alopecia), topical minoxidil
- Effect
- 5% solution gave 45% more regrowth than 2% at 48 weeks; both beat placebo
- Best fit
- Men aged 18 to 49 with moderate thinning on the top of the scalp
- Time
- Hair count gains by 16 weeks; trials ran to 48 weeks
female pattern hair loss, topical minoxidil
- Effect
- Risk ratio 1.93 for moderate to marked regrowth versus placebo; +13.18 hairs per cm2
- Best fit
- Adult women with gradual, hereditary thinning on the top of the scalp
- Time
- Months; the women's Drug Facts labels say results may take 4 to 6 months
pattern hair loss, low-dose minoxidil tablets (off-label)
- Effect
- No significant difference from topical minoxidil in hair density
- Best fit
- Adults with pattern hair loss in dermatology trials who were screened by a doctor
- Time
- Trials lasted 24 to 39 weeks
resistant high blood pressure, minoxidil tablets
- Effect
- Blood pressure about 27/10 mmHg lower at discharge than at the start of minoxidil
- Best fit
- Adults with chronic kidney disease whose blood pressure stays high despite several drugs, treated in hospital
- Time
- Days, during the hospital stay
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
male pattern hair loss (androgenetic alopecia), topical minoxidil
Disease adjunctIn a 48-week double-blind trial, 393 men aged 18 to 49 applied 5% minoxidil solution, 2% minoxidil solution or placebo twice daily. The 5% solution beat both 2% and placebo on non-vellus hair counts and on patient and investigator ratings of scalp coverage, worked earlier, and gave 45% more regrowth than 2% at week 48; itching and local irritation were more common with 5%. A 16-week trial in 352 men aged 18 to 49 found that 5% minoxidil foam raised hair counts more than placebo (P < .0001). A meta-analysis of good- or fair-quality randomized trials found 5% and 2% minoxidil superior to placebo in men (P < .00001), with high heterogeneity between studies. The trials measured hair counts and ratings on the top of the scalp over months, not effects on a receding front hairline.
Bottom line: Topical minoxidil, especially 5%, regrows some hair on the top of the scalp in men while it is used.
female pattern hair loss, topical minoxidil
Disease adjunctA 2016 Cochrane review of 47 trials in women (17 testing minoxidil) found that more women using minoxidil (mostly 2%) reported a moderate to marked increase in hair regrowth than with placebo: 157 of 593 versus 77 of 555 (risk ratio 1.93, 95% CI 1.51 to 2.47, moderate-quality evidence), confirmed by investigator ratings in 7 studies with 1,181 participants (risk ratio 2.35). Total hair count rose by 13.18 hairs per cm2 more than with placebo (low-quality evidence). In four trials with 1,006 participants, minoxidil 2% and 5% did not differ in regrowth or in adverse events. Adverse events with twice-daily 2% were not significantly more frequent than with placebo. Most included trials had unclear or high risk of bias, and quality of life was barely measured.
Bottom line: Topical minoxidil helps regrow hair in women with pattern hair loss, and 2% and 5% performed similarly.
pattern hair loss, low-dose minoxidil tablets (off-label)
Disease adjunctThis is not an FDA-approved use. In a 24-week double-blind trial in Brazil, 90 men aged 18 to 55 were randomized to 5 mg minoxidil tablets daily plus a placebo solution, or 5% topical minoxidil twice daily plus a placebo tablet; 68 finished. Oral minoxidil was not superior to topical: for terminal hair density the between-group difference was 3.1 hairs per cm2 on the front scalp (P = .27) and 23.4 hairs per cm2 on the crown (P = .09). Photographs favored the tablets on the crown only (P = .04). Unwanted body hair (hypertrichosis) occurred in 49% and headache in 14% of the tablet group. A 2025 meta-analysis of 4 randomized trials (279 patients, 24 to 39 weeks) found no difference between tablets and topical minoxidil in hair density (SMD 0.02) or hair diameter, but twice the rate of unwanted body hair with tablets (risk ratio 2.01, 95% CI 1.18 to 3.41). These trials compared the tablets with topical minoxidil, not with placebo, and none followed people for years.
Bottom line: Low-dose tablets worked about as well as topical minoxidil in short trials, with more unwanted body hair, and remain an unapproved use.
resistant high blood pressure, minoxidil tablets
Biomarker supportMinoxidil tablets are approved for severe high blood pressure that is not controlled by a diuretic plus two other drugs, but modern trials are scarce. In a retrospective review of 54 hospital inpatients (a study of resistant hypertension in chronic kidney disease) whose blood pressure stayed uncontrolled despite current drug combinations, adding minoxidil was associated with a fall in blood pressure from 162.4/83.2 mmHg when it was started to 135.8/72.8 mmHg at discharge, and the effect held across the subgroups analyzed. The study had no comparison group and did not measure strokes, heart attacks or survival.
Bottom line: Minoxidil can lower stubborn high blood pressure strongly, but the modern evidence is a small uncontrolled study and the drug needs close supervision.
How it works
How to take it
What to track
Bottom line: Tablets are a supervised, last-line blood pressure medicine whose dose your prescriber sets; the scalp products are used exactly as the Drug Facts label says, every day, for as long as you want to keep the regrowth.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning (minoxidil tablets): "Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents." The boxed warning adds that in experimental animals minoxidil caused several kinds of heart muscle lesions, that it must be given under close supervision, usually with a beta blocker and a diuretic, and that people with malignant hypertension or who take guanethidine should start it in hospital.
Fluid around the heart: pericardial effusion, sometimes with tamponade, was seen in about 3% of treated patients not on dialysis, especially with poor kidney function, and pericarditis has been reported. The label calls for close watch for heart-sac problems and an echocardiogram if they are suspected.
Salt and water retention and heart failure: without a diuretic, the tablets can retain several hundred milliequivalents of salt and water within days. Even with a diuretic, reversible swelling developed in about 10% of patients not on dialysis, and fluid in the belly (ascites) has been reported. Rarely, fluid retention that does not respond to treatment means the drug has to be stopped.
Fast heartbeat and angina: the tablets raise the heart rate, and angina may worsen or appear for the first time; the label says this can generally be prevented with a beta blocker or similar drug taken around the clock. The label also warns that lowering very severe high blood pressure too fast, especially with intravenous drugs, can cause fainting, stroke, heart attack or loss of vision or hearing; such events have not been clearly linked to minoxidil itself, but the label says treatment of malignant hypertension should start in hospital.
Rare serious skin and blood reactions with the tablets: blistering rashes, toxic epidermal necrolysis and Stevens-Johnson syndrome have rarely been reported, as have low platelet and white blood cell counts.
Effects on the body from topical products: the Drug Facts labels say to stop use and ask a doctor if chest pain, rapid heartbeat, faintness or dizziness, sudden unexplained weight gain, or swelling of the hands or feet occurs. The products are flammable, and if swallowed, the labels say to get medical help or contact a Poison Control Center right away; the men's 5% solution label says to keep it out of reach of children and pets.
Low-dose tablets for hair loss are an unapproved use. The tablet label says that minoxidil, in any formulation, to promote hair growth is not an approved indication and that homemade (extemporaneous) topical formulations made from minoxidil should be considered to share the full range of the tablets' contraindications, warnings and adverse reactions. A meta-analysis of studies of doses of 5 mg a day or less found no significant change in systolic or diastolic blood pressure, a small rise in heart rate (2.67 beats a minute) and symptoms of low blood pressure in 5.0% of patients; the studies lacked control groups.
Who should avoid it
- People with pheochromocytoma (an adrenal tumor) or a past allergy to any ingredient: minoxidil tablets are contraindicated
- People who had a heart attack in the past month (the tablets have not been used in them), and people with kidney failure or on dialysis, who may need smaller doses and close supervision
- For topical products: anyone under 18; people whose hair loss is sudden or patchy, has no family history, has an unknown cause, or (women's products) is linked to childbirth; people whose scalp is red, inflamed, infected, irritated or painful, or who use other medicines on the scalp. The men's 5% products are labeled for men only. People with heart disease should ask a doctor before use
Pregnancy & breastfeeding
Pregnancy: the tablet label (Pregnancy Category C) says there are no adequate studies in pregnant women and that the tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. In rabbits, high doses raised fetal loss, and excess hair growth in newborns has been reported after exposure to minoxidil during pregnancy. The topical Drug Facts labels say the products may be harmful if used when pregnant. Breastfeeding: the tablet label reports minoxidil in the breast milk of one woman taking 5 mg twice daily and says the tablets should not be given to a nursing woman; the topical labels say the products may be harmful if used when breast-feeding. Talk with your doctor about pregnancy plans and feeding your baby.
Interactions
Minoxidil tablets do not cause dizziness on standing by themselves, but the label warns that giving them to someone already taking guanethidine can cause profound drops in blood pressure on standing. The label says guanethidine should, if possible, be stopped well before minoxidil starts, or minoxidil should be started in hospital. Your prescriber manages any change.
In its overdose section, the tablet label says that exaggerated low blood pressure is most likely when the body's usual blood pressure reflexes are blocked by earlier treatment with guanethidine-like or alpha-blocking drugs. Tell your prescriber and pharmacist about every blood pressure medicine you take.
The Drug Facts labels for topical minoxidil say not to use it if you use other medicines on the scalp. Ask your doctor or pharmacist before combining scalp treatments.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is oral minoxidil approved for hair loss?⌄
No. Minoxidil tablets are approved only for severe high blood pressure, and their label says that using minoxidil tablets, in any formulation, to promote hair growth is not an approved indication. Doctors sometimes prescribe low doses off-label. Small trials found results similar to topical minoxidil, with more unwanted body hair, so it is a decision for you and a prescriber who checks your heart and blood pressure.
Does the tablet work better than the solution or foam?⌄
In the trials so far, not clearly. A 24-week trial in 90 men found 5 mg tablets were not superior to 5% topical minoxidil, and a meta-analysis of 4 trials (279 patients) found no difference in hair density. The tablets doubled the rate of unwanted body hair.
Will my hair fall out if I stop?⌄
The Drug Facts labels say continued use is necessary to increase and keep regrowth, or hair loss will begin again. With the tablets, extra body hair also fades within 1 to 6 months after stopping.
Can women use the men's 5% minoxidil?⌄
The men's 5% solution and foam are labeled for use by men only. Women's Rogaine comes as a 5% foam used once a day and a 2% solution used twice a day. In a Cochrane review of trials in women, 2% and 5% performed similarly.
Can I take minoxidil with my supplements?⌄
There are no studies of minoxidil with supplements, and our database lists no supplement, food or drink interactions for it. The labels do list medicine interactions: the tablets with guanethidine and other drugs that block blood pressure reflexes, and the topical products with other medicines used on the scalp. Ask your doctor or pharmacist to check your full list, including supplements.
Is minoxidil safe during pregnancy or breastfeeding?⌄
The topical labels say it may be harmful if used when pregnant or breast-feeding. The tablet label says the tablets should be used in pregnancy only if the benefit justifies the risk, and should not be given to a nursing woman, because minoxidil has been found in breast milk. Talk with your doctor.
References by claim
male pattern hair loss (androgenetic alopecia), topical minoxidil
female pattern hair loss, topical minoxidil
van Zuuren et al., 2016 · PMC (2016) link
pattern hair loss, low-dose minoxidil tablets (off-label)
resistant high blood pressure, minoxidil tablets
Mundt et al., 2016 · PMC (2016) link
Safety
Minoxidil tablets prescribing information (Par Health) · DailyMed (FDA label) link
Men's Rogaine Extra Strength 5% minoxidil topical solution, Drug Facts · DailyMed (FDA label) link
Women's Rogaine 5% minoxidil topical foam, Drug Facts · DailyMed (FDA label) link
Chen et al., 2025 · PubMed (2025) link
Vañó-Galván et al., 2021 · PubMed (2021) link
Women's Rogaine 2% minoxidil topical solution, Drug Facts · DailyMed (FDA label) link
Men's Rogaine 5% minoxidil topical foam, Drug Facts · DailyMed (FDA label) link
Track Minoxidil with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published research and FDA labeling for educational purposes and is not medical advice. Follow the label, and ask your doctor or pharmacist before combining this medicine with supplements or other medicines.
